ArticleFrontiers in endocrinology2024

GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy.

Ahlima Roumane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.